Figure 5From: Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study Changes in mean central macular thickness from baseline. Patients with macular edema at months 3 and 6 in different study groups.Back to article page